Apixaban superior to rivaroxaban in preventing recurrent venous thromboembolism, major bleeding - Healio

Apixaban superior to rivaroxaban in preventing recurrent venous thromboembolism, major bleeding  Healio

Apixaban appeared more effective than rivaroxaban in preventing recurrent venous thromboembolism without major bleeding events, according to results of a ...



Comments

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review